I Aydogdu Selected Research

VAD protocol

12/2000

Bilateral transient hearing loss associated with vincristine therapy: case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Aydogdu Research Topics

Disease

2	Multiple Myeloma 09/2010 - 12/2000
2	Neoplasms (Cancer) 01/2006 - 06/2003
2	Pain (Aches) 03/2005 - 01/2001
2	Thrombocytopenia (Thrombopenia) 07/2003 - 01/2001
2	Bilateral Hearing Loss 06/2003 - 12/2000
2	Sudden Hearing Loss (Sudden Deafness) 06/2003 - 12/2000
2	Pernicious Anemia 12/2001 - 12/2000
2	Deglutition Disorders (Dysphagia) 01/2001 - 12/2000
1	Appendicitis 01/2017
1	Hemifacial Spasm 01/2007
1	Facial Paralysis (Facial Palsy) 01/2007
1	Hodgkin Disease (Hodgkin's Disease) 11/2005
1	Endometrial Neoplasms (Endometrial Cancer) 01/2005
1	Neoplasm Metastasis (Metastasis) 01/2005
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2003
1	Lymphedema (Milroy Disease) 05/2002
1	Bronchial Spasm 05/2002
1	Erysipeloid 05/2002
1	Fever (Fevers) 05/2002
1	Breast Neoplasms (Breast Cancer) 05/2002
1	Malignant Mesothelioma 05/2002
1	Pruritus (Itching) 05/2002
1	Exanthema (Rash) 05/2002
1	Anemia 01/2001
1	Leukopenia 01/2001
1	Zygomycosis (Phycomycosis) 01/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2000
1	Atrophy 12/2000
1	Hearing Loss (Hearing Impairment) 12/2000
1	Metaplasia 12/2000
1	Inflammation (Inflammations) 12/2000
1	Atrophic Gastritis 12/2000
1	Blast Crisis (Blast Phase) 04/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2000
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2000
1	Thrombocytosis (Thrombocythemia) 01/2000

Drug/Important Bio-Agent (IBA)

3	Vincristine (Oncovin)FDA LinkGeneric 06/2003 - 12/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2003 - 12/2000
2	InterferonsIBA 12/2000 - 04/2000
1	Therapeutic UsesIBA 01/2017
1	Bosentan (Tracleer)FDA Link 01/2017
1	Endothelin-1 (Endothelin 1)IBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2010
1	Bortezomib (Velcade)FDA Link 09/2010
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2007
1	Amikacin (A.M.K)FDA LinkGeneric 01/2006
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2006
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2006
1	Meropenem (Merrem)FDA LinkGeneric 01/2006
1	Oxidants (Oxidizing Agents)IBA 11/2005
1	Free RadicalsIBA 11/2005
1	AntioxidantsIBA 11/2005
1	IronIBA 07/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2003
1	NucleosidesIBA 05/2002
1	Antineoplastic Agents (Antineoplastics)IBA 05/2002
1	Gemcitabine FDA Link 05/2002
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2001
1	Oxidoreductases (Dehydrogenase)IBA 12/2001
1	Hemoglobins (Hemoglobin)IBA 12/2001
1	BilirubinIBA 12/2001
1	liposomal amphotericin B FDA Link 01/2001
1	Alkaline PhosphataseIBA 01/2001
1	Lidocaine (Xylocaine)FDA LinkGeneric 12/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2000
1	AntralIBA 12/2000
1	N 30IBA 12/2000
1	Prednisone (Sone)FDA LinkGeneric 12/2000
1	Interferon-alpha (Interferon Alfa)IBA 04/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2000
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2000
1	CytokinesIBA 01/2000

Therapy/Procedure

4	Therapeutics 06/2003 - 04/2000
2	Drug Therapy (Chemotherapy) 11/2005 - 12/2000
2	Radiotherapy 01/2005 - 05/2002
1	Kidney Transplantation 09/2010
1	Transplantation 09/2010
1	Operative Surgical Procedures 03/2005
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 07/2003
1	Electrodes (Electrode) 01/2001
1	Transcranial Magnetic Stimulation 01/2001
1	VAD protocol 12/2000